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Supplemental Methods:  
Adjudication of the final diagnosis 
The first step in the adjudication process was to decide whether there was syncope or not. If the criteria for a true syncope were not 
fulfilled, a distinction between the following non-syncopal disorders was made: pre-syncope; falls; stroke/TIA; epilepsy; metabolic 
disorders: e.g. hypoglycaemia, hypoxia, hyperventilation; intoxication: e.g. alcohol, benzodiazepines, opiates; functional (psychogenic 
pseudosyncope); others. 
The classification of syncope is based on pathophysiological considerations. The following predefined differential diagnoses were used: 
1) Cardiac syncope: We distinguished between: 
a. Arrhythmia as primary cause: Arrhythmias are the most common cause of syncope; Bradycardia: sinus node dysfunction, 
atrioventricular conduction system disease, implanted device malfunction or drug-induced; Tachycardia: supraventricular 
or ventricular. 
b. Structural heart disease: structural heart diseases can cause syncope when circulatory demands outweigh the impaired 
ability of the heart to increase output. However, in some cases syncope may not solely be the result of restricted cardiac 
output, but be in part due to an inappropriate reflex. However, when a structural heart disease was the primary cause or 
contributed most to syncope, it was classified as cardiovascular syncope. 
c. Others: pulmonary embolism, acute aortic dissection, pulmonary hypertension or any other cause for a cardiovascular 
syncope. 
2) Reflex (neutrally-mediated) syncope: This syncope is characterized by cardiovascular reflexes which are normally useful in 
controlling circulation but become intermittently inappropriate in response to a trigger. The reflex results in vasodilation and/or 
bradycardia which lead to a fall in arterial blood pressure and consequently to cerebral hypoperfusion. Identifying a trigger is 
central when diagnosing a reflex syncope. Typically symptoms as lightheadedness, nausea, sweating, weakness or visual 
disturbances precede reflex syncope. We distinguished between: 
a. Vasovagal: “common faint”, triggered by emotional distress/ pain or mediated by orthostatic stress. 
b. Situational: refers to reflex syncope associated with some specific circumstances, e.g. post-micturition, post-prandial, 
gastrointestinal stimulation, cough. 
c. Carotid sinus syncope: triggered by mechanical manipulation of the carotid sinus. It can be diagnosed by carotid sinus 
massage. 
d. Atypical forms: reflex syncope occurring with uncertain or apparently absent triggers. 
3) Syncope due to orthostatic hypotension: Orthostatic hypotension is defined as an abnormal decrease in systolic blood pressure 
after changing from supine to standing position. Key can be syncope immediately after standing up or a pathological Schellong 
test. We distinguished between: 
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a. Primary autonomic failure: There is an autonomic failure which is clearly a primary part of Parkinson syndrome as 
idiopathic Parkinson disease or atypical Parkinson syndrome (multiple system atrophy, progressive supranuclear 
oculomotoric paresis, corticobasal degeneration or lewy body dementia). 
b. Secondary autonomic failure: autonomic failure may be due to circumstances such as diabetes, uraemia, amyloidosis or 
spinal cord injuries 
c. Drug-induced orthostatic hypotension: orthostatic hypotension is due to drugs which can lead to orthostatic hypotension 
such as diuretics, antidepressants, vasodilators, alcohol 
d. Volume depletion: orthostatic hypotension is caused by a hypovolemia due to haemorrhage, diarrhoea, vomiting or fever 
e. Others: sometimes the pathophysiology remains unclear. 
4) Others, non-cardiac syncope: Sometimes the underlying pathophysiological mechanism of syncope remains unclear, but a cardiac 
syncope is ruled-out. 
5) Syncope of unknown etiology (cardiac syncope possible): the etiology of syncope still remained unknown and a cardiac syncope 
was considered to be a possible cause. 
Supplemental Figures:  
Supplemental figure 1 : Patient flow-chart.  






Supplemental figure 2: Accuracy of the analyzed scores for the prediction of death or MACE at 30 days, as given by value the Area Under the 
Curve. 
 





Supplemental Tables :  
 
Supplemental table 1 : Details of the score computation  
Score Variable Definition of the variable Computation with our data Computation 
oft he score  
CHADS2  Congestive heart 
failure 
Patients with clinical diagnostic of heart failure or 
LVEF<40% or NYHA Class II-IV 
If the patient had a clinical history of heart failure (NYHA II-IV) 
or an EF of <40% on the TTE 
+1 
Hypertension BPSys>140 or BPdiast>90 or 1 anti-hypertensive med.  If the patient had a history of hypertension or if he was under a 
chronic treatment of at least one alphablocker and/or one 
diuretic and/or one ACE-inhibitor and/or one AT-II blocker 
and/or one betablocker and/or one calcium antagonist.  
+1 
Age > 75yo  If age >75yo +1 
DM  Previous diagnosis or use of antidiabetic medications If the patient had a diagnosis of diabetes or was using 
antidiabetics, including insulin.  
+1 
History of Stroke 
or TIA 
 If the patient had a previous diagnosis of stroke or TIA +2 
CHA2DS2VASc Age >65yo  Age>65yo. +1 
Vascular disease History of myocardial infarction, peripheral artery 
disease or vascular plaques, including previous surgery 
for vessels or previous arterial and venous thrombosis.  
If the patient had a diagnosis of peripheral artery disease, a 
history of a previous myocardial infarction, deep vein 
thrombosis, a coronary artery bypass or a percutaneous 
coronary revascularisation.   
+1 
Sex Female If the patient was a woman +1 
OESIL score Cardiovascular 
disease 
1. Previous clinical or laboratory diagnosis of any form 
of structural heart disease, including ischemic heart 
disease, valvular dysfunction and primary myocardial 
disease, 
2. Previous diagnosis or clinical evidence of congestive 
heart failure, 
3. Previous diagnosis or clinical evidence of peripheral 
arterial disease, 
4. Previous diagnosis of stroke or transient ischemic 
attack. 
 
If the patient had a history of congestive heart failure (NYHA II-
IV), a known valvular disease, a previous history of stroke or 
TIA, myocardial infarction, bypass operation, percutaneous 
coronary revascularisation or a diagnosis of peripheral artery 
disease. 
+1 
No prodromi No prodromal symptoms such as light-headedness, 
nausea, diaphoresis, weakness, and visual 
disturbances  
If the patients had no prodromal symptoms such as light-
headedness, nausea, vomiting, diaphoresis, weakness, and 
visual disturbances.  
+1 
Abnormales EKG The tracings were considered abnormal in the following 
cases: 
The tracings were considered abnormal in the following cases: 
1. Rhythm abnormalities : Atrial fibrillation, atrial flutter, 
+1 
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1. Rhythm abnormalities (atrial fibrillation or flutter, 
supraventricular tachycardia, multi- focal atrial 
tachycardia, frequent or repetitive premature 
supraventricular or ventricular com- plexes, sustained 
or non-sustained ventricular tachycardia, paced 
rhythms), 
2. Atrioventricular or intraventricular conduction 
disorders (complete atrioventricular block, Mobitz I or 
Mobitz II atrioventricular block, bundle branch block or 
intraventricular conduction delay), 
3. Left or right ventricular hypertrophy, 
4. Left axis deviation, 
 5. Old myocardial infarction, 
6. ST segment and T wave abnormalities consistent 
with or possibly related to myocardial ischemia. 
Electrocardiographic recordings showing non- specific 
repolarization abnormalities were not considered as 
abnormal. 
 
atrial ectopic rhythm, ventricular ectopic rhythm 
2. Atrioventricular block Mobitz I and II, complete 
atrioventricular block or higher atrioventricular blocks, 
right, left left-anterior hemi- and bundle branch block 
3. Left ventricular hypertrophy  
4. Left axis deviation 
5. Presence of significant Q-waves 
6. ST segments modification and T wave abnormalities 
possibly related to myocardial ischemia 
Age >65yo  Age >65yo  
EGSYS score  Palpitation 
preceding 
syncope 
 If the patient reported palpitations preceding the event.  +4 
History of Heart 
disease or 
abnormal ECG in 
the ED 
ECG abnormality was considered as the presence of 
one or more of the following abnormalities: bradycardia 
(<40 beat/minute), ST changes (>1 mm elevation or 
depression), QT prolongation (440ms), ventricular 
tachycardia, atrioventricular block (second or third 
degree), sick sinus syndrome, ventricular and rapid 
paroxysmal supraventricular arrhythmias, sinus pauses, 
and pace malfunction. 
No precisions given regarding the “history of heart 
disease” component.  
The tracings were considered abnormal in the following cases: 
1. Bradycardia <40bpm 
2. Rhythm abnormalities : Atrial fibrillation, atrial flutter, 
atrial ectopic rhythm, ventricular ectopic rhythm and 
pacemaker rhythm 
3. Sicksinus syndrome 
4. Atrioventricular block Mobitz I and II, complete 
atrioventricular block or higher atrioventricular blocks 
5. ST segments modification and T wave abnormalities 
possibly related to myocardial ischemia 
6. QT prolongation (440ms) 
A history of heart disease was positive if the patient had a 
diagnosis of congestive heart failure (NYHA II-IV), of valve 
disease, a previous history of myocardial infarction, bypass 




 If the patient reported syncope during effort.  +3 
Syncope while 
supine 
 If the patient reported syncope while supine. +2 




as the presence of one or more of the following 
abnormalities: Warm-crowded place/prolonged 
orthostasis/fear–pain–emotion  
 




Prodromal symptoms and signs were considered as the 
presence of one or more of the following abnormalities: 
nausea/vomiting 
If the patients had no prodromal symptoms such as light-
headedness, nausea, vomiting, diaphoresis, weakness, and 
visual disturbances. 
-1 




 If the patient had a known history of congestive heart failure 
(NYHA II-IV) 
1 
Arrhythmia Definition of arrhythmia: ventricular tachycardia (VT) of 
three or more beats; sinus pauses of 2 seconds or 
longer and those pauses that were symptomatic; 
symptomatic sinus bradycardia ("symptomatic" for the 
purposes of this study refers to the simultaneous 
occurrence of dizziness, lightheadedness, or  syncope 
and an arrhythmia on ECG monitoring); supra- 
ventricular tachycardia (SVT) with symptoms or 
associated with hypotension (systolic blood pressure 
less than 90 mm Hg); atrial fibrillation with slow 
ventricular response (RR interval longer than 3 
seconds); complete atrioventricular block; Mobitz II 
atrioventricular block; and evidence of pacemaker 
malfunction.  
Isolated, asymptomatic premature ventricular 
contractions (PVCs), couplets, asymptomatic premature 
atrial contractions, brief asymptomatic runs of SVT, 
chronic atrial fibrillation, and atrial flutter were not 
included in the definition of arrhythmias unless they 
were associated with symptoms (dizziness, 
lightheadedness, or syncope). 
If the patient had any known history of arrhythmia. 1 
Abnormal ECG:  
 
ECG reports and tracings (from ED ECG, Holter 
monitoring, or bedside ECG monitoring in the CCU) 
were reviewed for identification and verification of 
arrhythmias. Two definitions of clinically important 
arrhythmias were considered. It was not required that 
these arrhythmias were the cause of the syncope.  
Rhythm abnormalities were : atrial fibrillation or flutter, 
multifocal atrial tachycardia, junctional or paced 
rhythms; frequent or repetitive PVCs (including VT), 
conduction disorders (ie, left axis deviation, bundle 
branch block, intraventricular conduction delay), left or 
ECG reports from the ED ECG, Holter monitoring and 
telemetry monitoring data were review.  
Abnormal parameters on the ECG were considered to be :  
1. Rhythm abnormalities : Atrial fibrillation, atrial flutter, 
atrial ectopic rhythm, ventricular ectopic rhythm 
2. Atrioventricular block Mobitz I and II, complete 
atrioventricular block or higher atrioventricular blocks, 
right, left left-anterior hemi- and bundle branch block 
or a PQ-time <0.10sec 
3. Left ventricular hypertrophy  
4. Left axis deviation 
1 
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right ventricular hypertrophy (LVHor RVH), short 
PRinterval (less than 0.10sec), old myocardialinfarction, 
and atrioventricular block (ie, complete atrioventricular 
block, Mobitz II, or Mobitz I with other abnormalities 
present). 
Not abnormal: normal (including patients with only sinus 
bradycardia or sinus tachycardia); nonspecific ST- and 
T-wave abnormalities (NST) for patients with NST as 
the only abnormality 
 
5. Presence of significant Q-waves 
6. ST segments modification and T wave abnormalities 
possibly related to myocardial ischemia 
7. Presence of nonsustained ventricular tachycardia 
Abnormal parameters on the Holter analysis were considered 
to be:  
1. Rhythm abnormalities : Atrial fibrillation, atrial flutter, 
atrial ectopic rhythm, ventricular ectopic rhythm 
2. Atrioventricular block Mobitz I and II, complete 
atrioventricular block or higher atrioventricular blocks 
3. Incomplete and complete right, left blocks or 
combinations.  
4. Any pause >2.5 sec 
The telemetry monitoring data were considered abnormal if 
any pause of >2.5sec occurred.  
SFSR 
 
Abnormal ECG New abnormal ECG All ECGs upon arrival in the ED were compared with 
previously realized ECGs (anytime).  
A new pathology was considered when the ECG upon arrival 
but not the previous ECG displayed at least one of:  
1. Atrioventricular block Mobitz I and II, complete 
atrioventricular block or higher atrioventricular blocks, 
right, left left-anterior hemi- and bundle branch block 
2. Left ventricular hypertrophy  
3. Left axis deviation 
4. Presence of significant Q-waves 
5. ST segments modification and T wave abnormalities 
possibly related to myocardial ischemia 
6. Presence of nonsustained ventricular tachycardia 
7. QTc time >440 
8. Sick sinus syndrome 
Any rhythm abnormality (Atrial fibrillation, atrial flutter, atrial 
ectopic rhythm, ventricular ectopic rhythm), even already 
present on the previous ECG, was considered abnormal.  
Made the rule 
positive 
Dyspnea  If the patient reported dyspnea before or after the event. Made the rule 
positive 
Hematocrit <30  If the haematocrit upon arrival was <30 Made the rule 
positive 
Systolic BP <90  If the systolic BP upon arrival was <90 Made the rule 
positive 
HF  If the patient had a clinical history of heart failure (NYHA II-IV) 
or an EF of <40% on the TTE 
Made the rule 
positive 
STEPS short term 
 
Abnormal ECG Electrocardiogram (ECG) was defined as abnormal in 
the presence of any of the following: 1) atrial fibrillation 
If any of:  
1. Rhythm abnormalities : Atrial fibrillation, atrial flutter 
6.9 
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or tachycardia; 2) sinus pause >2 s; 3) sinus 
bradycardia with heart rate ranging between 35 and 45 
beats/min; 4) conduction disorders (i.e., bundle branch 
block, second-degree Mobitz I atrioventricular block); 5) 
ECG signs of previous 
myocardial infarction or ventricular hypertrophy; and 6) 
multiple premature ventricular beats. 
or heart rate >100 bpm or <45bpm 
2. Atrioventricular block Mobitz I, complete 
atrioventricular block or higher atrioventricular blocks, 
right, left left-anterior hemi- and bundle branch block 
3. Left ventricular hypertrophy  
4. Left axis deviation 
5. Presence of significant Q-waves 
6. ST segments modification and T wave abnormalities 
possibly related to myocardial ischemia 
7. Presence of nonsustained ventricular tachycardia 
 
Trauma  If the patient reported any injury 2.9 
No prodrome  If the patients had no prodromal symptoms such as light-
headedness, nausea, vomiting, diaphoresis, weakness, and 
visual disturbances. 
2.4 
Male Sex  Male sex 2.2 
STEPS  Long 
term 
 




 If the patient displayed any diagnosis of leucemia, malignant 





 If the patient had any history of stroke or TIA 2.5 
Structural heart 
disease 
 A history of heart disease was positive if the patient had a 
diagnosis of congestive heart failure (NYHA II-IV), of valve 
disease, a previous history of myocardial infarction, bypass 




 If the patient reported any diagnosis of arrhythmia 3.9 
Boston  Signs and 
symptoms of ACS 
Complaint of CP 
Ischemic ECG changes (ST elevation or deep ST 
depression) 
Other ECG changes : VT, VF, SVT, rapid AF or new 
ST/T wave change 
Complaint of SOB 
If the patient reported any complain of chest pain/dyspnea 
before or after the syncope, if the ECG upon arrival to the ED 
was showing Q-waves, ST elevation or deep ST depression, 
VT, VF or AF.  




Hx of CAD, cardiomyopathy 
Hx of congestive HF or LV dysfunction 
Hx of Ventricular tachycardia or VF 
Hx of PM, ICD 
Prehosp use of antidysrhythmic meds but not BB or Ca-
blockers 
If the patient reported any history of arrhythmia, diagnosis of 
CHF (NYHA II-IV), showed a LV dysfunction in the TTE, had a 
Pacemaker, ICD or CRT, had a history of AMI, bypass, PCI, 
were taking antiarrhythmic class I medication or digitalis.  
Made the rule 
positive 





Heart murmur noted on examination or in history If the patient reported any diagnosis of valvular disease or if a 
systolic or diastolic murmur was noticed during physical 
examination.  





Multiple syncopal episodes within the last 6 mo 
Rapid heart beat by patient history 
Syncope during exercise 
QT interval >500 
2nd or 3rd degree AV block or intraventricular block 
If the patient reported syncope during exercise, any history of 
palpitations or more than 2 previous syncopal events.   
If the QTc interval was >500, if the ECG showed any of :  
1. Atrioventricular block Mobitz I, complete 
atrioventricular block or higher atrioventricular blocks, 
right, left left-anterior hemi- and bundle branch block 
2. QTc>500ms 
Made the rule 
positive 
Volume depletion GI bleeding by haemoccult or history 
Hct<30 
Dehydration not corrected in the ED by physician 
If the patient reported any GI bleeding during the last week, if 
there were signs of GI bleeding upon arrival to the ED or if 
haematocrit was lower than 30.  





signs in the ED  
Respiratory rate >24/min 
O2 saturation <90% 
SR <50bpm or >100bpm 
BP <90mmHg 
If respiratory rate >24/min 
O2 saturation <90% 
SR <50bpm or >100bpm 
BP <90mmHg 




SAH or stroke If a bleeding or acute ischemia was present on the cranial CT 
or if the patients received a discharge diagnosis of stroke or 
TIA.   






Supplemental table 2: Effectiveness of the different scores for the risk stratification for death (B) and MACE (C) and for the diagnosis of 
cardiac syncope (C) when the recommended cut-off is used:  
Percentage of patients ruled in and out, sensitivity (SE), specificity (SP), negative predictive value (NPV) and positive predictive value 
(PPV). There is no recommended cut-off for the CHADSVasc and both STEPS scores.  
 
 




% of patients 
ruled in 
% of patients 
ruled out 
SE SP NPV PPV 
CHADS ≥1 82,5 17,5 96,8 20,0 97,3 17,2 
OESIL ≥2 52,1 47,9 79,9 52,7 93,8 22,6 
EGSYS ≥3 14,2 85,8 18,3 86,5 86,0 18,9 
Boston ≥1 99,4 0,6 100,0 0,7 100,0 14,8 
SFSR ≥1 71,0 29,0 84,0 31,2 91,9 17,4 
Martin ≥1 95,8 4,2 100,0 4,9 100,0 15,3 
 




% of patients 
ruled in 
% of patients 
ruled out 
SE SP NPV PPV 
CHADS ≥1 82,5 17,5 94,1 20,5 93,1 23,5 
OESIL ≥2 52,1 47,9 75,6 54,0 89,5 29,9 
EGSYS ≥3 14,2 85,8 18,9 87,0 80,5 27,4 
Boston ≥1 99,4 0,6 99,7 0,7 88,9 20,7 
SFSR ≥1 71,0 29,0 85,7 32,8 89,8 24,9 
Martin ≥1 95,8 4,2 99,7 5,2 98,4 21,4 
 
3C) Effectiveness for the diagnosis of cardiac syncope 
 
Score Recommended % of patients % of patients SE SP NPV PPV 
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cut-off ruled in ruled out 
CHADS ≥1 81,0 19,0 93,1 21,3 94,1 18,4 
OESIL ≥2 49,4 50,6 74,5 55,4 91,9 24,2 
EGSYS ≥3 14,3 85,7 23,6 87,4 85,7 26,4 
Boston ≥1 99,3 0,7 100,0 0,8 100,0 16,2 
SFSR ≥1 70,0 30,0 89,4 33,7 94,3 20,5 
Martin ≥1 95,5 4,5 100,0 5,3 100,0 16,8 
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Supplemental table 3: Details of the performance for CHADS2, OESIL, EGSYS and Martin when different cut-offs are assessed.  
 
A) Characteristics of the scores for the prediction of death 
CHADS         
Cutoff % ruled-in % ruled-out SE SP NPV PPV % with events 
in rule-in 
% with events 
in rule-out 
≥0 82,5 17,5 96,8 20 97,3 17,2 14,2 0,5 
≥1 50,7 49,3 84 55 95,2 24,3 12,3 2,3 
≥2 19,2 80,8 34,7 83,5 88,1 26,6 5,1 9,6 
≥3 7,5 92,5 11,4 93,2 85,9 22,3 1,7 13 
≥4 1,7 98,3 1,8 98,3 85,3 15,4 0,3 14,4 
≥5 0,2 99,8 0,5 99,8 85,3 33,3 0,1 14,6 
≥6 0 100 0 100 85,3 #N/A 0 14,7 
 
        OESIL         
Cutoff % ruled-in % ruled-out SE SP NPV PPV % with events 
in rule-in 
% with events 
in rule-out 
≥0 100 0 100 0 #N/A 14,7 14,7 0 
≥1 79 21 95,9 23,9 97,1 17,8 14,1 0,6 
≥2 52,1 47,9 79,9 52,7 93,8 22,6 11,7 3 
≥3 25,6 74,4 46,6 78 89,4 26,8 6,8 7,9 
≥4 5,6 94,4 13,7 95,8 86,6 36,1 2 12,7 
 
        EGSYS         
Cutoff % ruled-in % ruled-out SE SP NPV PPV % with events 
in rule-in 
% with events 
in rule-out 
≥-2 100 0 100 0 #N/A 14,7 14,7 0 
≥-1 100 0 100 0 #N/A 14,7 14,7 0 
≥0 69,2 30,8 84 33,4 92,4 17,8 12,3 2,3 
≥1 69,1 30,9 84 33,4 92,4 17,9 12,3 2,3 
≥2 68,7 31,3 83,6 33,9 92,3 17,9 12,3 2,4 
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≥3 14,2 85,8 18,3 86,5 86 18,9 2,7 12 
≥4 11,5 88,5 16 89,3 86,1 20,5 2,3 12,3 
≥5 10,3 89,7 13,7 90,3 85,9 19,6 2 12,7 
≥6 4,5 95,5 4,6 95,5 85,3 14,9 0,7 14 
≥8 0,4 99,6 0,9 99,7 85,4 33,3 0,1 14,6 
≥9 0,4 99,6 0,9 99,7 85,4 33,3 0,1 14,6 
≥10 0 100 0 100 85,3 #N/A 0 14,7 
         
Martin         
Cutoff % ruled-in % ruled-out SE SP NPV PPV % with events 
in rule-in 
% with events 
in rule-out 
≥0 95,8 4,2 100 4,9 100 15,3 14,7 0 
≥1 56,8 43,2 78,1 46,8 92,5 20,2 11,5 3,2 
≥2 22,8 77,2 42,5 80,6 89,1 27,4 6,2 8,5 
≥3 4,1 95,9 9,6 96,9 86,1 34,4 1,4 13,3 
≥4 0 100 0 100 85,3 #N/A 0 14,7 
 
B) Characteristics of the scores for the prediction of MACE 
CHADS         
Cutoff % ruled-in % ruled-out SE SP NPV PPV % with events 
in rule-in 
% with events 
in rule-out 
≥0 82,5 17,5 96,8 20 97,3 17,2 14,2 0,5 
≥1 50,7 49,3 84 55 95,2 24,3 12,3 2,3 
≥2 19,2 80,8 34,7 83,5 88,1 26,6 5,1 9,6 
≥3 7,5 92,5 11,4 93,2 85,9 22,3 1,7 13 
≥4 1,7 98,3 1,8 98,3 85,3 15,4 0,3 14,4 
≥5 0,2 99,8 0,5 99,8 85,3 33,3 0,1 14,6 
≥6 0 100 0 100 85,3 #N/A 0 14,7 
 
        OESIL         
Cutoff % ruled-in % ruled-out SE SP NPV PPV % with events % with events 
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in rule-in in rule-out 
≥0 100 0 100 0 #N/A 20,6 20,6 0 
≥1 79 21 94,5 25 94,6 24,6 19,5 1,1 
≥2 52,1 47,9 75,6 54 89,5 29,9 15,6 5 
≥3 25,6 74,4 46,9 80 85,3 37,8 9,7 10,9 
≥4 5,6 94,4 11,7 96 80,7 43,4 2,4 18,2 
 
        EGSYS         
Cutoff % ruled-in % ruled-out SE SP NPV PPV % with events 
in rule-in 
% with events 
in rule-out 
≥-2 100 0 100 0 #N/A 14,7 14,7 0 
≥-1 100 0 100 0 #N/A 14,7 14,7 0 
≥0 69,2 30,8 84 33,4 92,4 17,8 12,3 2,3 
≥1 69,1 30,9 84 33,4 92,4 17,9 12,3 2,3 
≥2 68,7 31,3 83,6 33,9 92,3 17,9 12,3 2,4 
≥3 14,2 85,8 18,3 86,5 86 18,9 2,7 12 
≥4 11,5 88,5 16 89,3 86,1 20,5 2,3 12,3 
≥5 10,3 89,7 13,7 90,3 85,9 19,6 2 12,7 
≥6 4,5 95,5 4,6 95,5 85,3 14,9 0,7 14 
≥8 0,4 99,6 0,9 99,7 85,4 33,3 0,1 14,6 
≥9 0,4 99,6 0,9 99,7 85,4 33,3 0,1 14,6 
≥10 0 100 0 100 85,3 #N/A 0 14,7 
         
Martin         
Cutoff % ruled-in % ruled-out SE SP NPV PPV % with events 
in rule-in 
% with events 
in rule-out 
≥0 100 0 100 0 #N/A 20,6 20,6 0 
≥1 95,8 4,2 99,7 5,2 98,4 21,4 20,5 0,1 
≥2 56,8 43,2 84,4 50,3 92,5 30,6 17,4 3,2 
≥3 22,8 77,2 43,6 82,7 85 39,5 9 11,6 
≥4 4,1 95,9 8,5 97 80,3 42,6 1,7 18,9 
 18 
C) Characteristics of the scores for the diagnosis of cardiac syncope 
CHADS         
Cutoff % ruled-in % ruled-out SE SP NPV PPV % with events 
in rule-in 
% with events 
in rule-out 
≥0 100 0 100 0 #N/A 16,1 16,1 0 
≥1 81 19 93,1 21,3 94,1 18,4 14,9 1,1 
≥2 48 52 69,4 56,1 90,6 23,2 11,2 4,9 
≥3 17,7 82,3 27,3 84,1 85,8 24,8 4,4 11,7 
≥4 6,9 93,1 11,1 93,9 84,7 25,8 1,8 14,3 
≥5 1,6 98,4 3,2 98,7 84,2 31,8 0,5 15,5 
≥6 0,2 99,8 0,5 99,8 84 33,3 0,1 16 
         
OESIL         
Cutoff % ruled-in % ruled-out SE SP NPV PPV % with events 
in rule-in 
% with events 
in rule-out 
≥0 100 0 100 0 #N/A 16,1 16,1 0 
≥1 77,2 22,8 93,1 25,8 95,1 19,3 14,9 1,1 
≥2 49,4 50,6 74,5 55,4 91,9 24,2 12 4,1 
≥3 23,8 76,2 53,7 81,9 90,2 36,2 8,6 7,4 
≥4 5,1 94,9 13 96,5 85,3 41,2 2,1 14 
         
EGSYS         
Cutoff % ruled-in % ruled-out SE SP NPV PPV % with events 
in rule-in 
% with events 
in rule-out 
≥-2 100 0 100 0 #N/A 16,1 16,1 0 
≥-1 100 0 100 0 #N/A 16,1 16,1 0 
≥0 67,7 32,3 90,3 36,6 95,2 21,4 14,5 1,6 
≥1 67,7 32,3 90,3 36,7 95,2 21,4 14,5 1,6 
≥2 67,3 32,7 89,8 37 95 21,4 14,4 1,6 
≥3 14,3 85,7 23,6 87,4 85,7 26,4 3,8 12,3 
≥4 11,4 88,6 21,8 90,5 85,8 30,5 3,5 12,6 
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≥5 10,2 89,8 19,9 91,7 85,7 31,4 3,2 12,9 
≥6 4,6 95,4 6,9 95,8 84,3 24,2 1,1 14,9 
≥8 0,4 99,6 0,9 99,6 84 33,3 0,1 15,9 
≥9 0,4 99,6 0,9 99,6 84 33,3 0,1 15,9 
≥10 0 100 0 100 83,9 #N/A 0 16,1 
         
Martin         
Cutoff % ruled-in % ruled-out SE SP NPV PPV % with events 
in rule-in 
% with events 
in rule-out 
≥0 100 0 100 0 #N/A 16,1 16,1 0 
≥1 95,5 4,5 100 5,3 100 16,8 16,1 0 
≥2 55,3 44,7 89,4 51,2 96,2 25,9 14,3 1,7 
≥3 21,9 78,1 48,1 83,1 89,3 35,3 7,7 8,3 
≥4 3,9 96,1 8,3 97 84,7 34,6 1,3 14,7 
 
#N/A = not applicable 
 
Supplemental Table 4: Comparison of the added value of different scores on top of the Clinical judgement of the ED physician for the 
prediction of cardiac syncope. 
Score AUC 
Clinical judgment 0.868 
(95%-CI  0.840-0.897) 
Clinical judgment +CHADS 0.871  
(95%-CI  0.845-0.898) 
(p=0.89) 
Clinical judgment + CHADSVasc 0.874  
(95%-CI  0.848-0.899) 
(p=0.79) 
Clinical judgment +OESIL 0.880  
(95%-CI  0.855-0.905) 
(p=0.54) 
Clinical judgment +Martin 0.880  
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(95%-CI  0.855-0.905) 
(p=0.54) 
* p are given for the comparison with the clinical judgment alone. 
 
 
